Outcomes in Necrotizing Enterocolitis (NEC) Treated with Granulocyte Colony Stimulating Factor (GCSF) and Intravenous Immunoglobulin (IVIG) vs Standard of Care Alone: RCT Interim Safety Analysis

Authors

Sanjeet Panda, New York Medical CollegeFollow
Courtney Briggs-Steinberg, New York Medical College
Brian DeBenedictis, New York Medical College
Sri Narayana, New York Medical College
Edmund F. La Gamma, New York Medical CollegeFollow

Document Type

Poster

Publication Date

3-22-2017

Department

Pediatrics

Keywords

Necrotizing Enterocolitis, intravenous immunoglobulin, GCSF

Disciplines

Analytical, Diagnostic and Therapeutic Techniques and Equipment | Digestive System Diseases | Pediatrics

Recommended Citation

Panda, S., Briggs-Steinberg, C., DeBenedictis, B., Narayana, S., & La Gamma, E. F. (2017). Outcomes in Necrotizing Enterocolitis (NEC) Treated with Granulocyte Colony Stimulating Factor (GCSF) and Intravenous Immunoglobulin (IVIG) vs Standard of Care Alone: RCT Interim Safety Analysis. Retrieved from https://touroscholar.touro.edu/nymc_fac_posters/24